Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stromal cell-derived factor 1 alpha (SDF-1α), also known as CXCL12-alpha, is a CXC chemokine that plays a crucial role in various biological processes, including immune cell trafficking, stem cell homing, tissue repair, and development. It primarily signals through the CXCR4 and CXCR7 receptors, activating downstream pathways like PI3K/Akt and MAPK/ERK. Its involvement in cancer progression, cardiovascular repair, and nervous system development makes it a target of interest for therapeutic interventions.
CXCR4 and CXCR7 receptor modulation, PI3K/Akt pathway activation, MAPK/ERK pathway activation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stromal Cell-Derived Factor 1 Alpha (SDF-1α).